Table 2.

Patient demographics of the donors in the tissue study

	(n = 10)	IPF (n = 10)	ILD (n = 8)
Median Age, years (SD)	60 (16)	61 (4)	60 (6)
Smoking History, n (%)	4 (40%)	7 (70%)	4 (50%)
Median Forced Vital Capacity (FVC), % predicted (SD)	n/a	43 (16)	48 (27)
Median Transfer Factor of Carbon Monoxide (TLCO), % predicted (SD	n/a	17 (8)	43 (13)

NDC non-diseased control, IPF idiopathic pulmonary fibrosis, ILD interstitial lung disease other than IPF. Non-IPF ILD diagnoses included non-specific interstitial pneumonia (NSIP, n = 2), chronic hypersenstitivity pneumonitis (HP, n = 4), connective tissue disease associated ILD (CTD-ILD, n = 2)